FR3039400B1 - NEW VETERINARY COMPOSITIONS FOR THE PREVENTION AND SIMULTANEOUS TREATMENT OF ENDOPARASITES AND ECTOPARASITES - Google Patents

NEW VETERINARY COMPOSITIONS FOR THE PREVENTION AND SIMULTANEOUS TREATMENT OF ENDOPARASITES AND ECTOPARASITES

Info

Publication number
FR3039400B1
FR3039400B1 FR1557170A FR1557170A FR3039400B1 FR 3039400 B1 FR3039400 B1 FR 3039400B1 FR 1557170 A FR1557170 A FR 1557170A FR 1557170 A FR1557170 A FR 1557170A FR 3039400 B1 FR3039400 B1 FR 3039400B1
Authority
FR
France
Prior art keywords
endoparasites
ectoparasites
prevention
simultaneous treatment
veterinary compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1557170A
Other languages
French (fr)
Other versions
FR3039400A1 (en
Inventor
Fanny Martins
Pierre JASMIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virbac SA
Original Assignee
Virbac SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac SA filed Critical Virbac SA
Priority to FR1557170A priority Critical patent/FR3039400B1/en
Priority to PCT/EP2016/067773 priority patent/WO2017017091A1/en
Publication of FR3039400A1 publication Critical patent/FR3039400A1/en
Application granted granted Critical
Publication of FR3039400B1 publication Critical patent/FR3039400B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
FR1557170A 2015-07-27 2015-07-27 NEW VETERINARY COMPOSITIONS FOR THE PREVENTION AND SIMULTANEOUS TREATMENT OF ENDOPARASITES AND ECTOPARASITES Active FR3039400B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1557170A FR3039400B1 (en) 2015-07-27 2015-07-27 NEW VETERINARY COMPOSITIONS FOR THE PREVENTION AND SIMULTANEOUS TREATMENT OF ENDOPARASITES AND ECTOPARASITES
PCT/EP2016/067773 WO2017017091A1 (en) 2015-07-27 2016-07-26 Novel veterinary compositions for the simultaneous prevention and treatment of endoparasites and ectoparasites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1557170A FR3039400B1 (en) 2015-07-27 2015-07-27 NEW VETERINARY COMPOSITIONS FOR THE PREVENTION AND SIMULTANEOUS TREATMENT OF ENDOPARASITES AND ECTOPARASITES

Publications (2)

Publication Number Publication Date
FR3039400A1 FR3039400A1 (en) 2017-02-03
FR3039400B1 true FR3039400B1 (en) 2017-08-18

Family

ID=54186166

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1557170A Active FR3039400B1 (en) 2015-07-27 2015-07-27 NEW VETERINARY COMPOSITIONS FOR THE PREVENTION AND SIMULTANEOUS TREATMENT OF ENDOPARASITES AND ECTOPARASITES

Country Status (1)

Country Link
FR (1) FR3039400B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA108641C2 (en) * 2010-04-02 2015-05-25 PARASITICID COMPOSITION CONTAINING FOUR ACTIVE AGENTS AND METHOD OF APPLICATION

Also Published As

Publication number Publication date
FR3039400A1 (en) 2017-02-03

Similar Documents

Publication Publication Date Title
MA45192A (en) ASSOCIATION TREATMENT
MA43135A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
MA43190A (en) TREATMENT OF MIXED DYSLIPIDEMIA
MA45481A (en) USE OF EXOSOMES FOR THE TREATMENT OF DISEASES
MA49144A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
MA43283A (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
MA41044A (en) COMPOSITIONS AND METHODS OF USE FOR INCREASED IMMUNE RESPONSE AND CANCER TREATMENT
MA41449A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCERS
FR3046933B1 (en) NLRP3 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
MA42439A (en) AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY
DK3277270T3 (en) COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF ANEMIA
MA47719A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
MA43000A (en) POLYTHERAPY FOR THE TREATMENT OF MALIGNANT TUMORS
MA54925A (en) COMPOSITIONS FOR THE TREATMENT OF ACID-BASED DISORDERS
MA48637A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
MA50409A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
HK1252813A1 (en) Therapeutic compounds and compositions for treating social disorders and substance use disorders
MA42999A (en) POLYTHERAPY FOR THE TREATMENT OF MALIGNITIES
MA42953A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
IT201600121601A1 (en) ORAL COMPOSITION FOR THE TREATMENT OF GASTROESOFAGEO REFLUX AND LARINGO-FARINGEO REFLUX
HK1251225A1 (en) Novel benzimidazole compound and pharmaceutical use of same
MA46086A (en) DOSAGE SCHEDULE FOR THE TREATMENT OF SOLID TUMORS
FR3022139B1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF SKIN FLAVORS AND ROSACEA
MA43825A (en) DOSAGE SCHEDULES FOR THE TREATMENT OF FUNGAL INFECTIONS
MA41629A (en) COMPOSITIONS AND METHODS OF USE OF ANTI-MÜLLERIAN HORMONE FOR THE TREATMENT OF INFERTILITY

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170203

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9